BeOne Medicines AG ONC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1,235.63% | 469.12% | 230.75% | 144.50% | 108.28% |
| Total Depreciation and Amortization | 2.59% | -17.80% | -20.11% | -21.16% | -27.54% |
| Total Amortization of Deferred Charges | 195.34% | -30.94% | 124.05% | 111.55% | 32.35% |
| Total Other Non-Cash Items | -5.66% | 1.78% | 7.34% | 3.78% | 7.08% |
| Change in Net Operating Assets | -395.50% | 270.34% | 199.93% | 221.46% | 101.67% |
| Cash from Operations | 102.47% | 159.81% | 505.99% | 901.80% | 228.44% |
| Capital Expenditure | 41.46% | 52.85% | 56.63% | 62.28% | 54.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.11% | 68.10% | 56.59% | -62.19% | 66.13% |
| Cash from Investing | 49.02% | 56.14% | 56.63% | 49.64% | 58.20% |
| Total Debt Issued | 20.33% | 20.33% | 31.78% | 23.59% | -8.21% |
| Total Debt Repaid | 4.43% | 4.77% | -0.57% | -47.55% | -159.01% |
| Issuance of Common Stock | -11.62% | 10.85% | 66.91% | 332.59% | 392.57% |
| Repurchase of Common Stock | 100.00% | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.83% | -- | 29,158.60% | 29,352.13% | 4,045.55% |
| Cash from Financing | -72.68% | 11,839.71% | 44,428.88% | 447.66% | 65.43% |
| Foreign Exchange rate Adjustments | 590.32% | 1,910.66% | 394.19% | 216.09% | -4.08% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 25.67% | 1,383.51% | 939.04% | 460.15% | 266.42% |